Painchek seeks FDA nod for pain detection device
Painchek is eyeing a US market of 1.7 million aged-care beds for its mobile-based pain detection tool.
Stockhead
Optiscan inks vet medicine research deal
Optiscan and the University of Minnesota College of Veterinary Medicine have inked a research deal exploring the clinical applications of the medtech’s technology in animal care.
ASX on a high as tech stocks lead
The ASX kissed a record high on Tuesday, led by tech, energy and gold stocks, with gold rising above US$2600.
Sun Silver spots resource growth potential in Nevada
Sun Silver assays highlight growth potential beyond its current 195.7Mt resource at Maverick Springs.
More Stories
IPT defines maiden Lake Hope measured resource
Impact Minerals expects to complete the pre-feasibility study for its Lake Hope high purity alumina project in Q1 2025
Neurizon’s lead drug confirms ALS treatment potential
Positive results of preclinical studies confirm the potential of Neurizon’s lead drug candidate NUZ-001 to be a transformative treatment for Amyotrophic Lateral Sclerosis (ALS).
Can Echo IQ keep things pumping?
With FDA approval in the bag for its AI-based aortic stenosis diagnostic tool, Echo IQ is focused on commercialisation over the next few years.
GT1 MD discusses ongoing drilling
Sarah Hughan sits down with Green Technology Metals’ MD, Cameron Henry, to discuss drilling at the Root lithium project in Ontario, Canada, and its potential to support a resource upgrade.
ASX flat but Alderan up on copper hit
The ASX is trading flat as US rate fears weigh. Meanwhile NAB has been hit by a lawsuit and new bank levy, and Alderan jumps on copper-drilling hit in the US.
The ASX’s cheapest silver explorer
With a market cap of just $6m, Silver hunter Sierra Nevada Gold may be the next cab off the rank in the ASX silver revival.
ASX up, uranium stocks rise
The ASX closing bell has rung, with the local bourse ending Monday on a positive note. Mining gains offset tech and bank losses, while uranium stocks soared.
Tungsten merger has tongues wagging
A $13.5m tungsten deal, a cheap silver explorer and a uranium enrichment play are among the Aussie resources stocks posting gains on Monday.
Tryptamine secures $6m for IV psilocin drug
Tryptamine has firm commitments to raise $6m in a placement to advance clinical development of its novel IV-infused psilocin formulation TRP-8803.
Test flights give Li-S Energy a lift
Li-S Energy’s commercial potential has lifted after the company successfully completed drone test flights powered by a 12-cell lithium sulfur battery pack.
Original URL: https://www.heraldsun.com.au/business/stockhead/page/3